PJ
Phoolwati Jain
About Phoolwati Jain
Data last updated:
Phoolwati Jain is a Director at Pharma Synth Formulations Limited (since 1994) and Director at B L D Exports Private Limited (since 2018). The companies operate in Pharma and Fashion and Textile. The largest current company by reported revenue is Pharma Synth Formulations Limited at ₹53.06 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Pharma Synth Formulations Limited U74899DL1993PLC056231 | Director | 08 Mar 1994 | 1993 | ₹53.06 Cr (FY 2024) | Active |
 B L D Exports Private Limited U74899DL1993PTC053602 | Director | 23 Oct 2018 | 1993 | Active |
Board colleagues of Phoolwati Jain
| Name | DIN | Company | Designation |
|---|---|---|---|
| Arvind Kumar Gupta | 00787256 | Pharma Synth Formulations Limited | Director |
| Ramesh Chand Jain | 00787319 | Pharma Synth Formulations Limited | Director |
| Kalpana Jain | 00596752 | B L D Exports Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Phoolwati Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Phoolwati Jain
Phoolwati Jain currently holds 2 directorships: Pharma Synth Formulations Limited (Director, since 08 Mar 1994, revenue ₹53.06 Cr (FY 2024)); B L D Exports Private Limited (Director, since 23 Oct 2018).
Phoolwati Jain was first appointed on 08 Mar 1994 as Director at Pharma Synth Formulations Limited. The most recent appointment on record is 23 Oct 2018 at B L D Exports Private Limited.
The current boards of Phoolwati Jain's companies include Arvind Kumar Gupta (Pharma Synth Formulations Limited), Ramesh Chand Jain (Pharma Synth Formulations Limited), Kalpana Jain (B L D Exports Private Limited).